A double-blind, randomized, placebo controlled clinical trial on comparing escitalopram and duloxetine add-on for negative symptoms in schizophrenic subjects with neuregulin-1 (NRG1) risk genotype

2010-01-012024-05-13https://scholars.lib.ntu.edu.tw/handle/123456789/647279A double-blind, randomized, placebo controlled clinical trial on comparing escitalopram and duloxetine add-on for negative symptoms in schizophrenic subjects with neuregulin-1 (NRG1) risk genotype